A detailed history of Public Sector Pension Investment Board transactions in Moderna, Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 13,880 shares of MRNA stock, worth $912,610. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,880
Previous 8,323 66.77%
Holding current value
$912,610
Previous $886,000 86.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $562,423 - $925,851
5,557 Added 66.77%
13,880 $1.65 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $17,074 - $23,088
-200 Reduced 2.35%
8,323 $886,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $1.87 Million - $2.81 Million
-26,946 Reduced 75.97%
8,523 $847,000
Q3 2023

Nov 22, 2023

BUY
$96.41 - $126.61 $393,063 - $516,188
4,077 Added 12.99%
35,469 $3.66 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $587,641 - $796,068
-4,959 Reduced 13.64%
31,392 $3.81 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $648,726 - $942,149
-4,782 Reduced 11.63%
36,351 $5.58 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $600,186 - $1.06 Million
5,070 Added 14.06%
41,133 $7.39 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $327,880 - $539,237
2,777 Added 8.34%
36,063 $4.26 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $12.4 Million - $18.7 Million
-106,044 Reduced 76.11%
33,286 $4.76 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $1.21 Million - $2.24 Million
-9,530 Reduced 6.4%
139,330 $24 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $299,888 - $489,381
-1,328 Reduced 0.88%
148,860 $37.8 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $33.3 Million - $72.8 Million
150,188 New
150,188 $57.8 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.